<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03421340</url>
  </required_header>
  <id_info>
    <org_study_id>E7131</org_study_id>
    <nct_id>NCT03421340</nct_id>
  </id_info>
  <brief_title>Non-Complex Biliary Stones DSC vs ERC</brief_title>
  <official_title>Prospective, Multi-center, Randomized Controlled Study Comparing Endoscopic Clearance of Non-Complex Biliary Stones Using Fluoroscopy/Radiation-Free Direct Solitary Cholangioscopy (DSC) to Standard of Care Endoscopic Retrograde Cholangiography (ERC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To prospectively compare non-complex biliary stone clearance using fluoroscopy/radiation-free
      direct solitary cholangioscopy (DSC) utilizing the SpyGlass™ system with non-complex biliary
      stone clearance using standard endoscopic retrograde cholangiography (ERC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to prospectively compare non-complex biliary stone clearance
      using fluoroscopy/radiation-free direct solitary cholangioscopy (DSC) utilizing the SpyGlass™
      system with non-complex biliary stone clearance using standard endoscopic retrograde
      cholangioscopy (ERC).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2018</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete stone clearance</measure>
    <time_frame>2 years</time_frame>
    <description>Prospectively compare DSC vs. ERC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse event evaluation</measure>
    <time_frame>2 years</time_frame>
    <description>To evaluate all SAEs including death, severity, onset, time to resolution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation Exposure</measure>
    <time_frame>2 years</time_frame>
    <description>Measure of radiation exposure from duodenoscope in to completion of stone clearance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Procedure</measure>
    <time_frame>2 years</time_frame>
    <description>Defined as time from duodenoscope in to completion of stone clearance.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Biliary Stones</condition>
  <arm_group>
    <arm_group_label>ERC Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>After screening examination and confirmed presence of non-complex bile duct stone by image, patients will be randomly assigned by stratified randomization to Electroscopic Retrograde Cholangioscopy (ERC) treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DSC Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>After screening examination and confirmed presence of non-complex bile duct stone by imagine, patients will be randomly assigned by stratified randomization to fluoroscopy/radiation-free direct solitary cholangioscopy (DSC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DSC</intervention_name>
    <description>Stone removal without fluoroscopy using the SpyGlass device.</description>
    <arm_group_label>DSC Arm</arm_group_label>
    <other_name>Direct Solitary Cholangioscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ERC</intervention_name>
    <description>Standard of care stone removal with fluoroscopy.</description>
    <arm_group_label>ERC Arm</arm_group_label>
    <other_name>Endoscopic Retrograde Cholangiography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years or older

          2. Abdominal pain consistent with choledocholithiasis (procedure possible within 72 hours
             of onset of symptoms and imaging suggesting choledocholithiasis, contingent on
             persistent abdominal pain)

          3. Abnormal LFTs

          4. Non-complex biliary stone disease, defined as 5 or fewer stones in the common bile or
             common hepatic duct with largest stone no larger than 10 mm in size. If stones not
             seen on imaging (US, CT) the bile duct diameter should be ≤12 mm*

             * Given the poor sensitivity (approximately 20%) for biliary stones of CT and US, the
             diameter of the dilated CBD is used as a surrogate for largest stone diameter

          5. Availability of non-invasive imaging to determine the diameter of the bile duct and
             number and size of bile duct stones if visible on imaging

               1. If probability of stones is high per investigator assessment based on ASGE
                  criteria, any standard of practice imaging modality (eg. abdominal US) is
                  acceptable.

               2. If the probability of stones is either intermediate or low per investigator
                  assessment based on ASGE criteria, MRCP or EUS imaging is required to confirm
                  presence of stones.

          6. Willing and able to comply with the study procedures and provide written informed
             consent to participate in the study

        Exclusion Criteria:

          1. Potentially vulnerable subjects, including but not limited to pregnant women and
             subjects in whom an endoscopic procedure is contraindicated

          2. Location of the stones in intrahepatic ducts, cystic duct or proximal to strictures

          3. Bile duct stricture noted distal to stone on MRCP, which would make extraction without
             lithotripsy impossible

          4. Ongoing cholangitis at time of randomization, manifested by fever with tachycardia and
             hypotension or evidence of pus at the ampulla

          5. Patients with prior biliary sphincterotomy

          6. Patients with Primary Sclerosing Cholangitis (PSC)

          7. Acute pancreatitis, defined as abdominal pain and serum concentration of pancreatic
             enzymes [lipase (required), amylase (optional)] three or more times the upper limit of
             normal

          8. Surgically altered gastro-duodenal luminal anatomy other than prior Billroth I
             reconstruction, as these would be anticipated to lead to more complicated procedures

          9. Coagulopathy or ongoing need for anti-coagulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subhash Banerjee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nirav Thosani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univeristy of Texas Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raj J Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohan Ramchandani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institure of Gastroenterology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guido Costamagna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundazione Policlinico Universitario</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Bruno, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rungsun Rerknimitr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Chulalongkorn Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janak N Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ochsner Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takao Itoi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokyo Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahesh Goenka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Apollo Gleneagles Hospitals, Kolkata</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Kennedy</last_name>
    <phone>508-683-4807</phone>
    <email>Elizabeth.Kennedy@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Srey Yin</last_name>
    <phone>508-683-4162</phone>
    <email>srey.yin@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Subhas Banerjee, MD</last_name>
      <email>sbanerje@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital, Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj J Shah, MD</last_name>
      <email>Raj.Shah@ucdenver.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janak Shah, MD</last_name>
      <email>janak.shah@ochsner.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ertan Digestive Disease Center - University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nirav Thosani, MD</last_name>
      <email>Nirav.Thosani@uth.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asian Institute of Gastroenterology</name>
      <address>
        <city>Hyderabad</city>
        <state>Somajiguda</state>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohan Ramchandani, MD</last_name>
      <email>ramchandanimohan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Apollo Gleneagles Hospitals Kolkata</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700054</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mahesh Goenka, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Shivraj Afzalpurkar, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fundazione Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Costamagna, MD</last_name>
      <email>Guido.Costamagna@Unicatt.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical University</name>
      <address>
        <city>Shinjuku-Ku</city>
        <state>Tokyo</state>
        <zip>160-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Takao Itoi, MD</last_name>
      <email>itoi@tokyo-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - University Medical Center of Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Bruno, MD</last_name>
      <email>m.bruno@erasmusmc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Pathum Wan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rungsun Rerknimitr, MD</last_name>
      <email>ercp@live.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Thailand</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 30, 2018</study_first_submitted>
  <study_first_submitted_qc>February 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2018</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>DSC</keyword>
  <keyword>Spy Glass</keyword>
  <keyword>Biliary Stones</keyword>
  <keyword>Choledocholithiasis</keyword>
  <keyword>Non-Complex</keyword>
  <keyword>Stones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

